86
Views
9
CrossRef citations to date
0
Altmetric
Research Article

IN VITRO PERCUTANEOUS ABSORPTION OF ACRYLAMIDE AND STYRENE FROM COSMETIC VEHICLES THROUGH FUZZY RAT AND HUMAN SKIN

&
Pages 65-79 | Published online: 10 Oct 2008

REFERENCES

  • The Cosmetic Ingredient Review. Final report on the safety assessment of polyacrylamide. J Am Coll Toxicol 1991; 10:193–203.
  • The Cosmetic Ingredient Review. Tentative Amended Report of the Cosmetic Ingredient Review Expert Panel, Washington, DC, February 7, 2003: Cosmetic Ingredient Review, Washington, DC, pp. 1–59.
  • Dybing E, Sanner T. Forum: Risk assessment of acrylamide in foods. Toxicol Sci 2003; 75:7–15. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Tareke E, Rydberg P, Karlsson P, Erikson S, Tornqvist M. Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J Agric Food Chem 2002; 50:4998–5006. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • IARC. Acrylamide. IARC Monogr Eval of Carcinog Risks to Hum 1994; 60:389–433.
  • Frantz S, Dryzga M, Freshour N, Watanabe P. In vivo/in vitro determination of cutaneous penetration of residual monomer from polyacrylamides. Toxicologist 1985; 5(A39):10.
  • Frantz S, Dryzga M, Freshour N. In vivo/in vitro determination of cutaneous penetration by residual acrylamide monomer from polyacrylamide water solutions. Dow Chemical USA, Midland, Michigan, 48674, 1986:1–30.
  • Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CH, Friedman MA, Mast RW. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 1986; 85:154–168. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Solomon J, Fedyk J, Mukai F, Segal A. Direct alkylation of 2′-deoxynucleosides and DNA following in vitro reaction with acrylamide. Cancer Res 1985; 45:3465–3470. [PUBMED], [INFOTRIEVE]
  • Freidman MA, Dulak LH, Stedhan MA. A lifetime oncogenicity study in rats with acrylamide. Fund Appl Toxicol 1995; 27:95–105. [CSA], [CROSSREF]
  • Dearfield KL, Abernathy CO, Ottley MS, Branter JH, Hayes PF. Acrylamide, its metabolism, developmental and reproductive effects, genotoxicity, and carcinogenicity. Mutat Res 1988; 195:45–77. [PUBMED], [INFOTRIEVE]
  • Spencer PS, Schaumburg HH. A review of acrylamide neurotoxicity. Part I. Properties, uses, and human exposure. Canad J Neurol Sciences 1974; 1:143–150.
  • Miller MS, Spencer PS. The mechanism of acrylamide axonopathy. Annu Rev Pharmacol Toxicol 1985; 25:643–666. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • World Health Organization. Acrylamide. Environmental Health Criteria 1985; 49:1–121.
  • Sumner SC, Fennell TR, Moore TA, Chanas B, Gonzalez F, Ghanayem BI. Role of cytochrome P450 2E1 in the metabolism of acrylamide and acrylonitrile in mice. Chem Res Toxicol 1999; 12:1110–1116. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Abou-Donia MB, Ibrahim SM, Corcoran JJ, Lack L, Friedman MA, Lapadula DM. Neurotoxicity of glycidamide, an acrylamide metabolite, following intraperitoneal injections in rats. J Toxicol Environ Health 1993; 39:447–464. [PUBMED], [INFOTRIEVE]
  • O'Donoghue, JL. Aromatic hydrocarbons. In: Neurotoxicity of Industrial and Commercial Chemicals. Boca Raton, Florida: CRC Press, Inc.; 1985; Vol. 2, 127–137.
  • Institute for Local Self-Reliance. Are Styrene Food and Beverage Containers A Health Hazard? Institute for Local Self-Reliance Publication August 15, Washington, DC, 1990.
  • Dowty BJ, Laseter JL, Storet J. The transplantal migration and accumulation in blood of volatile organic constituents. Ped Res 1976; 10:696–701.
  • IARC. Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene. IARC Monogr Eval of Carcinog Risks to Hum 2002; 82:437–550.
  • McDougal 1JN, Jepson GW, Clewell III HJ, Gargas ML, Anderson ME. Dermal absorption of organic chemical vapors in rats and humans. Fund Appl Toxicol 1990; 14:299–308. [CSA], [CROSSREF]
  • Morgan DL, Cooper SW, Carlock DL, Sykora JJ, Sutton B, Mattie DR, McDougal JN. Dermal absorption of neat and aqueous volatile organic chemicals in the Fischer 344 rat. Environ Res 1991; 55:51–63. [PUBMED], [INFOTRIEVE]
  • World Health Organization. Guidelines for Drinking-water Quality. Recommendations. 2nd Edition. Vol. 1, World health Organization, Geneva, 1993; p. 67.
  • U.S. Code of Federal Regulations, Title 40, Sections 141.32(e)(47) and 141.61(a).
  • U.S. Code of Federal Regulations, Title 21, Section 176.170(a)(5).
  • Petrobras Energia, Products, Buenos Aires, Argentina, 2003.
  • Bronaugh RL, Stewart RF. Methods for in vitro percutaneous absorption studies VI: Preparation of the barrier layer. J Pharm Sci 1986; 75:487–491. [PUBMED], [INFOTRIEVE]
  • Bronaugh RL, Stewart RF, Congdon ER. Methods for in vitro percutaneous absorption studies II. Animal models for human skin. Toxicol Appl Pharmacol 1982; 62:481–488. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Bronaugh RL, Stewart RF. Methods for in vitro percutaneous absorption studies IV: The flow-through diffusion cell. J Pharm Sci 1985; 74:64–67. [PUBMED], [INFOTRIEVE]
  • Collier SW, Sheikh NM, Sakr A, Lichtin JL, Stewart RF, Bronaugh RL. Maintenance of skin viability during in vitro percutaneous absorption/metabolism studies. Toxicol Appl Pharmacol 1989; 99:522–533. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Bronaugh RL, Stewart RF, Simon M. Methods for in vitro percutaneous absorption studies VII: Use of excised human skin. J Pharm Sci 1986; 75:1094–1097. [PUBMED], [INFOTRIEVE]
  • BASF. Cosmet and Toiletries 1991; 106:105.
  • Ramsey J, Young J, Gorzinski S. Acrylamide: Toxicodynamics in rats. Dow Chemical USA, Midland, Michigan 48640 (1984).
  • Sumner SC, Williams CC, Snyder RW, Krol WL, Asgharian B, Fennell TR. Acrylamide: A comparison of metabolism and hemoglobin adducts in rodents following dermal, intraperitoneal, oral, or inhalation exposure. Toxicol Sci 2003; 75:260–270. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Marty JP, Vincent CM. In vitro percutaneous absorption of acrylamide across human skin. Report for SNF, SEPPIC, 75 Quai d'Orsay, 75321 Paris Cedex, 1998; 1–9.
  • Storm JE, Collier SW, Stewart RF, Bronaugh RL. Metabolism of xenobiotics during percutaneous penetration: Role of absorption rate and cutaneous enzyme activity. Fund Appl Toxicol 1990; 15:132–141. [CSA], [CROSSREF]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.